Drug-delivery strategy created for central vision loss caused by blood vessel growth at back of eye
Johns Hopkins biomedical engineers have teamed up with clinicians to create a new drug-delivery strategy for a type of central vision loss caused by blood vessel growth at the back of the eye, where such growth should not occur.